Insider Transactions in Q2 2022 at Ocular Therapeutix, Inc (OCUL)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 16
2022
|
Jeffrey S. Heier Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+15.71%
|
-
|
|
Jun 16
2022
|
Seung Suh Hong Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+50.0%
|
-
|
|
Jun 16
2022
|
Richard L Md Lindstrom Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+7.61%
|
-
|
|
Jun 16
2022
|
Charles M Warden Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+15.56%
|
-
|
|
Jun 16
2022
|
Leslie J. Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+39.94%
|
-
|
|
Jun 16
2022
|
Merilee Raines Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,933
+50.0%
|
-
|
|
May 12
2022
|
Jeffrey S. Heier Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
15,000
+27.78%
|
$45,000
$3.05 P/Share
|
|
May 12
2022
|
Richard L Md Lindstrom Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,469
+8.69%
|
$9,469
$1.22 P/Share
|